Entratympanic
Founded in 2009, Entratympanic LLC is a medical device company specializing in biological R&D.
Founded
2009Founded in 2009, Entratympanic LLC is a medical device company specializing in biological R&D.
Founded in 2009, Entratympanic LLC is a medical device company specializing in biological research and development. The company's core mission is to improve the standard of care for treating ear infections, particularly addressing the challenges posed by antimicrobial resistance. Entratympanic's flagship product, the EToscope, offers an innovative solution for diagnosing and managing ear infections more effectively. Their market focus includes healthcare providers and institutions seeking advanced medical technologies to combat common yet persistent health issues.
Entratympanic has garnered attention from notable investors and medical professionals who recognize the urgent need for better treatment options for ear infections. The company has made significant strides in the medical device industry, contributing to the ongoing conversation about antimicrobial resistance and its impact on public health. Through their pioneering work, Entratympanic aims to reduce reliance on traditional antibiotics, thereby mitigating the risk of resistance and improving patient outcomes globally.
Companies similar to Entratympanic include Sonix Medical Devices, Tympanogen, Endoclear and Cactus Medical.
Entratympanic was founded in 2009.
Entratympanic's headquarters is located in Medfield, MA, US.
Entratympanic's most recent funding round was for $25k (USD) in August 2013.
As of Aug 21, 2013, Entratympanic has disclosed funding of $25k (USD). Undisclosed round amounts are excluded.
Entratympanic has 6 employees as of Feb 5, 2024.
